ArticleThe Journal of clinical investigation2011

IL-6 trans-signaling licenses mouse and human tumor microvascular gateways for trafficking of cytotoxic T cells.

Daniel T Fisher et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.